MiR-200a impairs glioma cell growth, migration, and invasion by targeting SIM2-s

NeuroReport

Volumn 25, Issue 1, 2014, Pages 12-17

  Su, Yuhang ^a,b   He, Qiaowei ^c   Deng, Lin ^a,b   Wang, Juntao ^a,b   Liu, Qinglin ^a,b   Wang, Donghai ^a,b   Huang, Qibing ^a,b   Li, Gang ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

cell growth; glioma; invasion; migration; miR 200a; single minded homolog 2 short form

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; MICRORNA 200A; MICRORNA 221; MICRORNA 363; SINGLE MINDED HOMOLOG 2 SHORT FORM PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE TARGETING; GLIOMA CELL; GROWTH; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS;

EID: 84889879789     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0000000000000032     Document Type: Article

References (23)

1. Rainov NG, Heidecke V. Clinical development of experimental therapies for malignant glioma. Sultan Qaboos Univ Med J 2011; 11:5-28
2. Kaur H, Phillips-Mason PJ, Burden-Gulley SM, Kerstetter-Fogle AE, Basilion JP, Sloan AE, et al. Cadherin-11, a marker of the mesenchymal phenotype, regulates glioblastoma cell migration and survival in vivo. Mol Cancer Res 2012; 10:293-304
3. Qi S, Song Y, Peng Y, Wang H, Long H, Yu X, et al. ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma. PloS one 2012; 7:e38842
4. Yang L, Liu M, Gu Z, Chen J, Yan Y, Li J. Overexpression of SASH1 related to the decreased invasion ability of human glioma U251 cells. Tumour Biol 2012; 33:2255-2263
5. Zhou X, Hua L, Zhang W, Zhu M, Shi Q, Li F, et al. FRK controls migration and invasion of human glioma cells by regulating JNK/c-Jun signaling. J Neurooncol 2012; 110:9-19
6. He Q, Li G, Su Y, Shen J, Liu Q, Ma X, et al. Single minded 2-s (SIM2-s) gene is expressed in human GBM cells and involved in GBM invasion. Cancer Biol Ther 2010; 9:430-436
7. Goshu E, Jin H, Lovejoy J, Marion JF, Michaud JL, Fan CM. Sim2 contributes to neuroendocrine hormone gene expression in the anterior hypothalamus. Mol Endocrinol 2004; 18:1251-1262
8. Rachidi M, Lopes C, Charron G, Delezoide AL, Paly E, Bloch B, et al. Spatial and temporal localization during embryonic and fetal human development of the transcription factor SIM2 in brain regions altered in Down syndrome. Int J Dev Neurosci 2005; 23:475-484
9. DeYoung MP, Tress M, Narayanan R. Down's syndrome-associated Single Minded 2 gene as a pancreatic cancer drug therapy target. Cancer Lett 2003; 200:25-31
10. Kwak HI, Gustafson T, Metz RP, Laffin B, Schedin P, PorterWW. Inhibition of breast cancer growth and invasion by single-minded 2s. Carcinogenesis 2007; 28:259-266
11. Halvorsen OJ, Rostad K, Øyan AM, Puntervoll H, Bø TH, Stordrange L, et al. Increased expression of SIM2-s protein is a novel marker of aggressive prostate cancer. Clin Cancer Res 2007; 13:892-897
12. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136:215-233
13. Shukla GC, Singh J, Barik S. MicroRNAs: Processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol 2011; 3:83-92
14. DeYoung MP, Tress M, Narayanan R. Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors. Proc Natl Acad Sci USA 2003; 100:4760-4765
15. Aleman MJ, DeYoung MP, Tress M, Keating P, Perry GW, Narayanan R. Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells. Proc Natl Acad Sci USA 2005; 102:12765-12770
16. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435:834-838
17. Eades G, Yang M, Yao Y, Zhang Y, Zhou Q. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J Biol Chem 2011; 286:40725-40733
18. Eades G, Yao Y, Yang M, Zhang Y, Chumsri S, Zhou Q. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. J Biol Chem 2011; 286:25992-26002
19. Wu X, Zhao B, Li W, Chen Y, Liang R, Li L, et al. MiR-200a is involved in rat epididymal development by targeting beta-catenin mRNA. Acta Biochim Biophys Sin (Shanghai) 2012; 44:233-240
20. Xia H, Cheung WK, Sze J, Lu G, Jiang S, Yao H, et al. miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling. J Biol Chem 2010; 285:36995-37004
21. Xia H, Ng SS, Jiang S, Cheung WK, Sze J, Bian XW, et al. miR-200amediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem Biophys Res Commun 2010; 391:535-541
22. Korpal M, Kang Y. The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol 2008; 5:115-119
23. Van Jaarsveld MT, Helleman J, Berns EM, Wiemer EA. MicroRNAs in ovarian cancer biology and therapy resistance. Int J Biochem Cell Biol 2010; 42:1282-1290